New drug VIS954 passes first safety check in healthy volunteers
NCT ID NCT06212804
First seen May 01, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study was the first time a new drug called VIS954 was tested in humans. It involved 54 healthy adults to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects and measured drug levels in the blood. The goal was to gather early safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Visterra Clinical Site
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.